a success rate of 51.9% is unreliable and basically a junk r...
a success rate of 51.9% is unreliable and basically a junk rating with not much of credibility.
Truist Financial Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $18
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment